期刊文献+

芦丁渗透泵片片芯的处方组成研究

Prescription Form of Core of Rutin Osmotic Pump
下载PDF
导出
摘要 目的探讨芦丁渗透泵片的片芯处方组成。方法以体外释药行为和工艺成型的难易程度为指标,采用单因素法对低分子促渗剂、高分子促渗剂、黏合剂、稀释剂、崩解剂、阻滞剂的种类与用量进行考察。结果确定了芦丁渗透泵片片芯处方中低分子促渗剂为蔗糖,稀释剂为药用淀粉,黏合剂为10%聚乙烯吡咯烷酮(PVP)-乙醇,润滑剂为硬脂酸镁;常用高分子促渗剂聚氧乙烯(PEO)及阻滞剂羟丙甲纤维素(HPMC)、阿拉伯胶均会严重阻滞芦丁渗透泵片的体外释药;崩解剂微晶纤维素(MCC)对片芯高分子辅料黏性的改善效果不佳。结论单室单层型难溶性药物渗透泵片的常用片芯辅料种类不适合芦丁渗透泵片的制备,其片芯辅料还有待进一步的筛选和优化。 Objective To study the prescription form for core of rutin osmotic pump. Methods Single-factor method was applied to study the types and doses of infihration promoter with low and high-molecular-weight polymers, adhesive agent, diluting agent, disintegrating agent and blocker, by using in vitro drug release, as well as the molding process as indicators. Results The prescription form for rutin osmotic pump was composed as: sugar as low-molecular-weight infiltration promoter, medicinal starch as diluting agent, 10% PVP-ethanol as adhesives, stearate magnesium as lubricant; the common used PEO and HPMC retarded drug release in vitro; MCC was not good enough for adhesion. Conclusion The conventional core accessories for osmotic pump with insoluble drugs as a single-room and single-layer model are not suitable for rutin osmotic pump, proper ones of which need to be further screened and optimized.
出处 《医药导报》 CAS 2009年第12期1600-1604,共5页 Herald of Medicine
基金 四川省卫生厅课题(基金编号:050180)
关键词 芦丁 单室单层 渗透泵片 片芯处方 Rutin Single-room and single-layer Osmotic pump-chip Core prescription
  • 相关文献

参考文献6

  • 1MODI N B, LINDEMULDER B, OUPTA S K. Single-andmultipledose pharmacokinetics of an oralonce-a-dayosmotic controlled release ROS methy lphenidate HC1 fornmlation [J]. Clin Pharmocol,2000,40(4) :379 -388.
  • 2STEVENS R E, LIMSAKUN T, EVANS G,et al. Controlled multidose pharrnacwkinetic evaluation of two extended release carbamazepine formulations carbatro and tegreto [J]. J Pharm Sci, 1998,87(12) : 1531 - 1534.
  • 3PILLAY V, FASSIHI R. Evaluation and comparison of dissolutiondata derived from different modified release dosage forms:an altemativ emethod[ J]. J Contr Rel, 1998,55 ( 1 ) : 45.
  • 4LU E X,JIANG Z Q,ZHANG Q Z,et al. A water insoluble drug monolithic osmotic, tablet system uitilizring gum arabic as a osmmitic , suspending and expending agent[J].J Contr Rel,2003,92(3):375 - 282.
  • 5凌静,王华,李士敏,梁文权.酒石酸托特罗定渗透泵片的制备及释放度测定[J].中国现代应用药学,2006,23(5):372-374. 被引量:3
  • 6GOHEL M C ,PANCHAL M K. Novel use of similarity factors 2 and S for the development of diltiazem HCI modified. release tablets US ring a 32 factor N1 design[J]. Drug Dev Ind Pharm ,2002,28( 1 ) :77.

二级参考文献7

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部